5 analysts have expressed a variety of opinions on EyePoint Pharmaceuticals (NASDAQ:EYPT) over the past quarter, offering a diverse set of opinions from bullish to bearish.
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 3 | 2 | 0 | 0 | 0 |
| Last 30D | 1 | 0 | 0 | 0 | 0 |
| 1M Ago | 1 | 0 | 0 | 0 | 0 |
| 2M Ago | 1 | 1 | 0 | 0 | 0 |
| 3M Ago | 0 | 1 | 0 | 0 | 0 |
The 12-month price targets, analyzed by analysts, offer insights with an average target of $36.8, a high estimate of $44.00, and a low estimate of $33.00. Surpassing the previous average price target of $32.67, the current average has increased by 12.64%.
Deciphering Analyst Ratings: An In-Depth Analysis
An in-depth...
Login or create a forever free account to read this news
Sign up/Log in